New finding potentially prevents age-related metabolic disease
A new study by researchers at Yale University in New Haven, Connecticut, have discovered why bellow fat surrounding organs increases as people age, a finding that could offer new treatment possibilities for improving metabolic health and reduce the likelihood for diseases like diabetes and atherosclerosis that stem from inflammation. The research was published in the journal Cell Metabolism.
Previous work found that as people age, their body's ability to generate energy by burning belly fat is reduced. Consequently, fat that surrounds the internal organs increases in the elderly. Researchers had found that the immune cells necessary to the fat-burning process, called macrophages, were still active but their overall numbers declined as belly fat increased with aging.
Led by Vishwa Deep Dixit, DVM, PhD, a professor of comparative medicine and immunobiology, the latest study found that adipose B cells in belly fat unexpectedly proliferated as animals aged, contributing to increased inflammation and metabolic decline.
These adipose B cells are a unique source of inflammation, Dixit said in a statement. Normally, the B cells produce antibodies, and defend against infection. With aging, the increased adipose B cells become dysfunctional, contributing to metabolic disease, he said.
When they are working correctly, Dixit said, some B cells expand as needed to protect the body from infection, and then contract to baseline. But with aging, they don't contract in belly fat. "This predisposes an animal to diabetes and metabolic dysfunction, like inability to burn fat.
Dixit said he theorizes that this ongoing expansion may be due to increased human life expectancy, a pushing of the body's cells beyond their evolutionary limits. Several mechanisms in the body are not selected for longevity, he said.
Researchers discovered that adipose B cells expand by receiving signals from nearby macrophages. Relatedly, they found that by reducing the macrophage signal and by removing adipose B cells, they could reverse the expansion process, and protect against age-induced decline in metabolic health. This could lead to exciting possibilities for repurposing drugs to target these dysfunctional adipose B cells for improved health outcomes and to protect against metabolic disease, Dixit said.